Publications by authors named "Chintan Bavishi"
Article Synopsis
- The study investigated the characteristics and treatment patterns of Indian patients with type 2 diabetes mellitus (T2DM) using a fixed-dose combination (FDC) of glimepiride, metformin, and voglibose across 424 sites in India from March 2021 to September 2022.
- A total of 8,587 patients participated, with a mean age of about 55 years; findings revealed 35.23% were newly diagnosed, 54.79% had a family history of diabetes, and common risk factors included a sedentary lifestyle.
- The most frequently prescribed treatment was the FDC of 1 mg glimepiride, 500 mg metformin, and 0.2 mg voglib
